nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP3A4—bone cancer	0.753	1	CbGaD
Domperidone—CYP2B6—Cisplatin—bone cancer	0.0457	0.295	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—bone cancer	0.0306	0.198	CbGbCtD
Domperidone—ABCB1—Cisplatin—bone cancer	0.0234	0.151	CbGbCtD
Domperidone—ABCB1—Doxorubicin—bone cancer	0.0157	0.101	CbGbCtD
Domperidone—ABCB1—Methotrexate—bone cancer	0.0152	0.0982	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—bone cancer	0.0148	0.0955	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—bone cancer	0.0094	0.0608	CbGbCtD
Domperidone—Sertindole—CYP3A4—bone cancer	0.00115	0.24	CrCbGaD
Domperidone—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000948	0.0109	CbGpPWpGaD
Domperidone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000914	0.0105	CbGpPWpGaD
Domperidone—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000912	0.0105	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000865	0.00993	CbGpPWpGaD
Domperidone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000859	0.00986	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000846	0.0097	CbGpPWpGaD
Domperidone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000821	0.00942	CbGpPWpGaD
Domperidone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000815	0.00935	CbGpPWpGaD
Domperidone—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000806	0.00925	CbGpPWpGaD
Domperidone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000801	0.00919	CbGpPWpGaD
Domperidone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00079	0.00906	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000777	0.00892	CbGpPWpGaD
Domperidone—DRD3—GPCRs, Other—GRM1—bone cancer	0.000769	0.00883	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000732	0.0084	CbGpPWpGaD
Domperidone—Pimozide—CYP3A4—bone cancer	0.000699	0.146	CrCbGaD
Domperidone—Nefazodone—CYP3A4—bone cancer	0.000695	0.146	CrCbGaD
Domperidone—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000683	0.00783	CbGpPWpGaD
Domperidone—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000674	0.00774	CbGpPWpGaD
Domperidone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000666	0.00764	CbGpPWpGaD
Domperidone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000651	0.00747	CbGpPWpGaD
Domperidone—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000648	0.00744	CbGpPWpGaD
Domperidone—Trazodone—CYP3A4—bone cancer	0.000643	0.135	CrCbGaD
Domperidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00064	0.00734	CbGpPWpGaD
Domperidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000635	0.00728	CbGpPWpGaD
Domperidone—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000621	0.00713	CbGpPWpGaD
Domperidone—Pipotiazine—CYP3A4—bone cancer	0.000603	0.126	CrCbGaD
Domperidone—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000601	0.0069	CbGpPWpGaD
Domperidone—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000595	0.00683	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000595	0.00682	CbGpPWpGaD
Domperidone—Prochlorperazine—CYP3A4—bone cancer	0.000576	0.121	CrCbGaD
Domperidone—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000571	0.00655	CbGpPWpGaD
Domperidone—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000549	0.0063	CbGpPWpGaD
Domperidone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000545	0.00625	CbGpPWpGaD
Domperidone—DRD3—GPCRs, Other—SMO—bone cancer	0.000542	0.00622	CbGpPWpGaD
Domperidone—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000538	0.00617	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000509	0.00584	CbGpPWpGaD
Domperidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000494	0.00566	CbGpPWpGaD
Domperidone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000491	0.00564	CbGpPWpGaD
Domperidone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000468	0.00537	CbGpPWpGaD
Domperidone—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000442	0.00507	CbGpPWpGaD
Domperidone—DRD3—G alpha (i) signalling events—GRM4—bone cancer	0.000415	0.00477	CbGpPWpGaD
Domperidone—DRD3—G alpha (i) signalling events—RGS1—bone cancer	0.000415	0.00477	CbGpPWpGaD
Domperidone—Perphenazine—CYP3A4—bone cancer	0.000412	0.0863	CrCbGaD
Domperidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000403	0.00462	CbGpPWpGaD
Domperidone—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000398	0.00456	CbGpPWpGaD
Domperidone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000394	0.00452	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000393	0.00451	CbGpPWpGaD
Domperidone—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000389	0.00446	CbGpPWpGaD
Domperidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000374	0.00429	CbGpPWpGaD
Domperidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000341	0.00391	CbGpPWpGaD
Domperidone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000337	0.00386	CbGpPWpGaD
Domperidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000327	0.00375	CbGpPWpGaD
Domperidone—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000322	0.0037	CbGpPWpGaD
Domperidone—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000319	0.00366	CbGpPWpGaD
Domperidone—DRD2—G alpha (i) signalling events—GRM4—bone cancer	0.000318	0.00365	CbGpPWpGaD
Domperidone—DRD2—G alpha (i) signalling events—RGS1—bone cancer	0.000318	0.00365	CbGpPWpGaD
Domperidone—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000293	0.00337	CbGpPWpGaD
Domperidone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00028	0.00321	CbGpPWpGaD
Domperidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000276	0.00317	CbGpPWpGaD
Domperidone—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000276	0.00317	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—GNA11—bone cancer	0.000263	0.00302	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—EZH2—bone cancer	0.000262	0.003	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—GRM4—bone cancer	0.000252	0.00289	CbGpPWpGaD
Domperidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000237	0.00272	CbGpPWpGaD
Domperidone—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000235	0.00269	CbGpPWpGaD
Domperidone—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000234	0.00269	CbGpPWpGaD
Domperidone—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000231	0.00265	CbGpPWpGaD
Domperidone—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000227	0.0026	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—GRM1—bone cancer	0.000218	0.0025	CbGpPWpGaD
Domperidone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000204	0.00234	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—GNA11—bone cancer	0.000201	0.00231	CbGpPWpGaD
Domperidone—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000201	0.0023	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—EZH2—bone cancer	0.0002	0.0023	CbGpPWpGaD
Domperidone—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000198	0.00227	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—GRM4—bone cancer	0.000192	0.00221	CbGpPWpGaD
Domperidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000192	0.00221	CbGpPWpGaD
Domperidone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000175	0.00201	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000173	0.00199	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000171	0.00196	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.00017	0.00195	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000167	0.00192	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—GRM1—bone cancer	0.000167	0.00191	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000167	0.00191	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000162	0.00186	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000158	0.00181	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—SMO—bone cancer	0.000154	0.00176	CbGpPWpGaD
Domperidone—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000149	0.00171	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000148	0.0017	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—CDK4—bone cancer	0.000148	0.0017	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000147	0.00169	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000146	0.00168	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000145	0.00166	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000145	0.00166	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000143	0.00164	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—RGS1—bone cancer	0.000142	0.00163	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—GRM4—bone cancer	0.000142	0.00163	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000142	0.00163	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000141	0.00161	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—BRAF—bone cancer	0.00014	0.0016	CbGpPWpGaD
Domperidone—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000135	0.00155	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00013	0.00149	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000129	0.00148	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—RGS1—bone cancer	0.000129	0.00148	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—GRM4—bone cancer	0.000129	0.00148	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000126	0.00144	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00142	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—GRM1—bone cancer	0.000123	0.00141	CbGpPWpGaD
Domperidone—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000122	0.0014	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000121	0.00138	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000119	0.00136	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000118	0.00135	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—SMO—bone cancer	0.000118	0.00135	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000117	0.00134	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—MDM2—bone cancer	0.000117	0.00134	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NT5C3A—bone cancer	0.000117	0.00134	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000116	0.00133	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.000113	0.0013	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—GRM1—bone cancer	0.000112	0.00128	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.00011	0.00126	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.000109	0.00125	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.000109	0.00125	CbGpPWpGaD
Domperidone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000104	0.00119	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000104	0.00119	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000103	0.00118	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000102	0.00117	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000102	0.00117	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NDUFA12—bone cancer	0.000102	0.00117	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000101	0.00116	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GRM4—bone cancer	9.88e-05	0.00113	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—RGS1—bone cancer	9.88e-05	0.00113	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	9.84e-05	0.00113	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.81e-05	0.00113	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—JUN—bone cancer	9.53e-05	0.00109	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—GRM1—bone cancer	9.43e-05	0.00108	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	9.21e-05	0.00106	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.21e-05	0.00106	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NDUFA12—bone cancer	8.8e-05	0.00101	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—GSTP1—bone cancer	8.74e-05	0.001	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NT5C3A—bone cancer	8.62e-05	0.000989	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	8.62e-05	0.000989	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GRM1—bone cancer	8.56e-05	0.000983	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.47e-05	0.000972	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NT5C3A—bone cancer	8.42e-05	0.000966	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—GNA11—bone cancer	7.94e-05	0.000911	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—SMO—bone cancer	7.89e-05	0.000905	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NDUFA12—bone cancer	7.67e-05	0.00088	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GRM4—bone cancer	7.63e-05	0.000875	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RGS1—bone cancer	7.63e-05	0.000875	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.29e-05	0.000837	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NT5C3A—bone cancer	7.29e-05	0.000837	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—JUN—bone cancer	7.29e-05	0.000836	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NDUFA12—bone cancer	7.23e-05	0.000829	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—GNA11—bone cancer	7.21e-05	0.000828	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL3—bone cancer	7.2e-05	0.000826	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.74e-05	0.000774	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.65e-05	0.000763	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GRM1—bone cancer	6.61e-05	0.000759	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL3—bone cancer	6.54e-05	0.00075	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NT5C3A—bone cancer	6.36e-05	0.000729	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—TP53—bone cancer	6.29e-05	0.000722	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NDUFA12—bone cancer	6.12e-05	0.000702	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—GNA11—bone cancer	6.08e-05	0.000697	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—SMO—bone cancer	6.03e-05	0.000692	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NT5C3A—bone cancer	5.99e-05	0.000687	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GRM4—bone cancer	5.84e-05	0.000669	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RGS1—bone cancer	5.84e-05	0.000669	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GNA11—bone cancer	5.52e-05	0.000633	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL3—bone cancer	5.51e-05	0.000632	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.41e-05	0.00062	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.21e-05	0.000598	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ENO2—bone cancer	5.1e-05	0.000586	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NT5C3A—bone cancer	5.07e-05	0.000582	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GRM1—bone cancer	5.06e-05	0.00058	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL3—bone cancer	5e-05	0.000574	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TP53—bone cancer	4.81e-05	0.000552	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—DHFR—bone cancer	4.73e-05	0.000543	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NDUFA12—bone cancer	4.73e-05	0.000542	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.7e-05	0.000539	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SMO—bone cancer	4.66e-05	0.000534	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GNA11—bone cancer	4.42e-05	0.000508	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GNA11—bone cancer	4.26e-05	0.000489	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP3A4—bone cancer	4.01e-05	0.00046	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ATF1—bone cancer	3.96e-05	0.000454	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NT5C3A—bone cancer	3.92e-05	0.000449	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL3—bone cancer	3.86e-05	0.000443	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ENO2—bone cancer	3.77e-05	0.000433	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.7e-05	0.000424	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ENO2—bone cancer	3.69e-05	0.000423	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SMO—bone cancer	3.56e-05	0.000409	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—DHFR—bone cancer	3.5e-05	0.000402	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTP1—bone cancer	3.43e-05	0.000394	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—DHFR—bone cancer	3.42e-05	0.000393	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFBR2—bone cancer	3.3e-05	0.000379	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GNA11—bone cancer	3.27e-05	0.000375	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GNA11—bone cancer	3.26e-05	0.000374	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GNA11—bone cancer	3.2e-05	0.000367	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ENO2—bone cancer	3.2e-05	0.000367	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1R—bone cancer	3.11e-05	0.000357	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.1e-05	0.000356	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ATF1—bone cancer	3.03e-05	0.000348	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP3A4—bone cancer	2.97e-05	0.00034	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—DHFR—bone cancer	2.96e-05	0.00034	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL3—bone cancer	2.96e-05	0.000339	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP3A4—bone cancer	2.9e-05	0.000333	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ENO2—bone cancer	2.78e-05	0.000319	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GNA11—bone cancer	2.77e-05	0.000318	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ENO2—bone cancer	2.62e-05	0.000301	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—DHFR—bone cancer	2.58e-05	0.000296	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTP1—bone cancer	2.54e-05	0.000291	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.53e-05	0.00029	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP3A4—bone cancer	2.51e-05	0.000288	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.5e-05	0.000287	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTP1—bone cancer	2.48e-05	0.000285	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—DHFR—bone cancer	2.43e-05	0.000279	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GNA11—bone cancer	2.41e-05	0.000277	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1R—bone cancer	2.38e-05	0.000273	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GNA11—bone cancer	2.27e-05	0.000261	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KIT—bone cancer	2.25e-05	0.000259	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ENO2—bone cancer	2.22e-05	0.000255	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP3A4—bone cancer	2.19e-05	0.000251	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—bone cancer	2.15e-05	0.000246	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BRAF—bone cancer	2.12e-05	0.000243	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP3A4—bone cancer	2.06e-05	0.000237	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—DHFR—bone cancer	2.06e-05	0.000237	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—bone cancer	2.05e-05	0.000236	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GNA11—bone cancer	1.93e-05	0.000221	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—bone cancer	1.87e-05	0.000215	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—bone cancer	1.78e-05	0.000204	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—bone cancer	1.78e-05	0.000204	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—bone cancer	1.76e-05	0.000202	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP3A4—bone cancer	1.75e-05	0.0002	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.74e-05	0.000199	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KIT—bone cancer	1.73e-05	0.000198	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO2—bone cancer	1.72e-05	0.000197	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.000186	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—DHFR—bone cancer	1.59e-05	0.000183	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.00018	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JUN—bone cancer	1.54e-05	0.000177	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—bone cancer	1.5e-05	0.000172	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—bone cancer	1.49e-05	0.000171	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNA11—bone cancer	1.49e-05	0.000171	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—bone cancer	1.36e-05	0.000156	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—bone cancer	1.31e-05	0.000151	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—bone cancer	1.28e-05	0.000147	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—bone cancer	1.21e-05	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JUN—bone cancer	1.18e-05	0.000135	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—bone cancer	1.15e-05	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000132	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—bone cancer	1.11e-05	0.000128	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—bone cancer	1.02e-05	0.000117	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—bone cancer	9.7e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—bone cancer	9.28e-06	0.000107	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—bone cancer	9.14e-06	0.000105	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—bone cancer	7.79e-06	8.94e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—bone cancer	7.74e-06	8.88e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—bone cancer	5.97e-06	6.85e-05	CbGpPWpGaD
